Tag Archives: U.S.

‘The death toll would be enormous,’ Fauci says of herd immunity to coronavirus in the U.S.

Dr Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, testifies during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Capitol Hill in Washington, U.S. Kevin Dietsch | Reuters If the U.S. allowed the coronavirus to spread unchecked in an attempt to try to achieve so-called herd immunity, the… Read More »

U.S. government gives Moderna Inc $472 million for coronavirus vaccine development

A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »

Mayo Clinic tops Best Hospitals list released by U.S. News & World report

Mayo Clinic in Rochester, Minnesota (Google Earth) The Mayo Clinic in Rochester, Minnesota has topped the list of Best Hospitals in 2020-21 in U.S. News & World Report’s annual rankings, followed by the Cleveland Clinic and Johns Hopkins Hospital in Baltimore in the second and third spots, respectively. The rankings, ostensibly compiled to help readers… Read More »

More than half of U.S. now faces travel quarantine in New York tri-state region

The sun sets below the Manhattan Bridge on July 20, 2020 in New York City . Gary Hershorn | Corbis News | Getty Images New York Gov. Andrew Cuomo, New Jersey Gov. Phil Murphy and Connecticut Gov. Ned Lamont added 10 more states to their travel restrictions list Tuesday, now requiring people from 31 states to… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »